Aug 21, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
JAZZ Inks $1B Licensing Deal With Saniona for Epilepsy Drug
Jazz Pharmaceuticals strikes a $1B licensing deal with Saniona for SAN2355, an epilepsy drug designed to target seizure control more precisely.
Aug 19, 2025 • GlobeNewswire
NEUTRAL
Zymeworks Announces Participation in Upcoming Investor Conferences
VANCOUVER, British Columbia, Aug. 19, 2025 ( GLOBE NEWSWIRE ) -- Zymeworks Inc. ( Nasdaq: ZYME ) , a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, ...
Aug 19, 2025 • Benzinga
NEUTRAL
Zymeworks Announces Participation in Upcoming Investor Conferences - Zymeworks ( NASDAQ:ZYME )
VANCOUVER, British Columbia, Aug. 19, 2025 ( GLOBE NEWSWIRE ) -- Zymeworks Inc.
Aug 13, 2025 • Benzinga
NEUTRAL
Onco360 adds Modeyso™ ( dordaviprone ) to portfolio of Oncology and Rare Cancer therapies as a National Specialty Pharmacy Provider
LOUISVILLE, Ky., Aug. 13, 2025 ( GLOBE NEWSWIRE ) -- Onco360®, the nation's leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Jazz Pharmaceuticals for Modeyso™ ( dordaviprone ) .
Aug 12, 2025 • Benzinga
NEUTRAL
Artios Pharma Appoints Michael T. Andriole as CEO and Director to Advance Alnodesertib ( ART0380 ) into Late-stage Development
Mike Andriole brings approximately 25 years of experience in the biopharmaceutical industry and a successful track record of delivering new first-in-class oncology therapies in indications of high unmet need to patients where no approved treatment exists
Aug 11, 2025 • GlobeNewswire
SOMEWHAT-BULLISH
Zymeworks Strengthens Board of Directors with Appointments of Greg Ciongoli and Robert E. Landry
VANCOUVER, British Columbia, Aug. 11, 2025 ( GLOBE NEWSWIRE ) -- Zymeworks Inc. ( Nasdaq: ZYME ) , a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, ...